|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
EP0173552B1
(en)
|
1984-08-24 |
1991-10-09 |
The Upjohn Company |
Recombinant dna compounds and the expression of polypeptides such as tpa
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
|
EP1400536A1
(en)
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Method for making humanized antibodies
|
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
US6268213B1
(en)
|
1992-06-03 |
2001-07-31 |
Richard Jude Samulski |
Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
|
|
US5869305A
(en)
|
1992-12-04 |
1999-02-09 |
The University Of Pittsburgh |
Recombinant viral vector system
|
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
|
US6204059B1
(en)
|
1994-06-30 |
2001-03-20 |
University Of Pittsburgh |
AAV capsid vehicles for molecular transfer
|
|
WO1996037234A1
(en)
|
1995-05-23 |
1996-11-28 |
Thomas Jefferson University |
Intracellular immunization
|
|
US6093570A
(en)
|
1995-06-07 |
2000-07-25 |
The University Of North Carolina At Chapel Hill |
Helper virus-free AAV production
|
|
US5741683A
(en)
|
1995-06-07 |
1998-04-21 |
The Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
|
US6001650A
(en)
|
1995-08-03 |
1999-12-14 |
Avigen, Inc. |
High-efficiency wild-type-free AAV helper functions
|
|
US6207457B1
(en)
*
|
1995-09-08 |
2001-03-27 |
Avigen, Inc. |
Targeted nucleotide sequence delivery and integration system
|
|
US5952221A
(en)
|
1996-03-06 |
1999-09-14 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a first and second nucleic acid sequence
|
|
EP0931158A1
(en)
|
1996-09-06 |
1999-07-28 |
The Trustees Of The University Of Pennsylvania |
An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
|
|
US20070059302A1
(en)
|
1997-04-07 |
2007-03-15 |
Genentech, Inc. |
Anti-vegf antibodies
|
|
KR100816621B1
(ko)
|
1997-04-07 |
2008-03-24 |
제넨테크, 인크. |
항-ｖｅｇｆ 항체
|
|
US20020032315A1
(en)
|
1997-08-06 |
2002-03-14 |
Manuel Baca |
Anti-vegf antibodies
|
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
US6548286B1
(en)
|
1997-04-14 |
2003-04-15 |
Cell Genesys, Inc. |
Methods for increasing the efficiency of recombinant AAV product
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
US6146874A
(en)
|
1998-05-27 |
2000-11-14 |
University Of Florida |
Method of preparing recombinant adeno-associated virus compositions
|
|
AU780231B2
(en)
|
1998-11-10 |
2005-03-10 |
University Of North Carolina At Chapel Hill, The |
Virus vectors and methods of making and administering the same
|
|
AU2001238079A1
(en)
|
2000-02-09 |
2001-08-20 |
Med Immune, Inc. |
Antibody gene therapy with adeno-associated viral vectors
|
|
US7201898B2
(en)
|
2000-06-01 |
2007-04-10 |
The University Of North Carolina At Chapel Hill |
Methods and compounds for controlled release of recombinant parvovirus vectors
|
|
JP4608210B2
(ja)
|
2001-05-31 |
2011-01-12 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
キメラアルファウイルスレプリコン粒子
|
|
ES2330202T5
(es)
|
2001-09-06 |
2014-01-20 |
Alphavax, Inc. |
Sistemas vectores basados en replicones de alfavirus
|
|
MX359371B
(es)
|
2001-11-13 |
2018-09-25 |
Univ Pennsylvania |
Un metodo para detectar y/o identificar secuencias del virus adeno-asociado y aislamiento de secuencias novedosas identificadas de ese modo.
|
|
PT1453547T
(pt)
|
2001-12-17 |
2016-12-28 |
Univ Pennsylvania |
Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas
|
|
AU2003274397A1
(en)
|
2002-06-05 |
2003-12-22 |
University Of Florida |
Production of pseudotyped recombinant aav virions
|
|
US20040166091A1
(en)
|
2003-02-24 |
2004-08-26 |
Genvec, Inc. |
Materials and methods for treating disorders of the ear
|
|
WO2005017149A1
(en)
|
2003-06-03 |
2005-02-24 |
Cell Genesys, Inc. |
Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
|
|
US7485291B2
(en)
|
2003-06-03 |
2009-02-03 |
Cell Genesys, Inc. |
Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
|
|
EP2345731B1
(en)
|
2003-09-30 |
2015-10-21 |
The Trustees of the University of Pennsylvania |
Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
|
|
CA2553676A1
(en)
|
2004-01-28 |
2005-08-11 |
Research Development Foundation |
Human soluble neuropilin-1 primary polyadenylation signal and uses thereof
|
|
JP2008503590A
(ja)
|
2004-06-21 |
2008-02-07 |
メドトロニック・インコーポレーテッド |
組成物を細胞にデリバリーするための医学用システム及び方法
|
|
US7714119B2
(en)
|
2004-07-13 |
2010-05-11 |
Biosante Pharmaceuticals, Inc. |
AAV vector compositions and methods for enhanced expression of immunoglobulins using the same
|
|
WO2006012414A2
(en)
|
2004-07-20 |
2006-02-02 |
Critical Therapeutics, Inc. |
Novel polyadenylation signal for use in expression vectors
|
|
EP1771571A2
(en)
*
|
2004-07-30 |
2007-04-11 |
Targeted Genetics Corporation |
Recombinant aav based vaccine methods
|
|
US20060110364A1
(en)
|
2004-08-20 |
2006-05-25 |
Ludwig Institute For Cancer Research |
Vector-mediated delivery of polynucleotides encoding soluble VEGF receptors
|
|
ES2525067T3
(es)
|
2005-04-07 |
2014-12-17 |
The Trustees Of The University Of Pennsylvania |
Método de incremento de la función de un vector de AAV
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
|
HUE029445T2
(en)
|
2006-12-19 |
2017-02-28 |
Genentech Inc |
VEGF-specific antagonists for adjuvant and neoadjuvant therapy and treatment of early-stage tumors
|
|
US20090215178A1
(en)
|
2008-02-22 |
2009-08-27 |
Zequn Tang |
Methods to enhance the stability and homogeneity of transgene expression in clonal cell lines
|
|
CN102149825B
(zh)
|
2008-07-08 |
2015-07-22 |
Abbvie公司 |
前列腺素e2双重可变结构域免疫球蛋白及其用途
|
|
RU2636046C2
(ru)
|
2009-01-12 |
2017-11-17 |
Сайтомкс Терапьютикс, Инк |
Композиции модифицированных антител, способы их получения и применения
|
|
EP2443150B1
(en)
|
2009-06-17 |
2015-01-21 |
AbbVie Biotherapeutics Inc. |
Anti-vegf antibodies and their uses
|
|
WO2011028811A2
(en)
|
2009-09-01 |
2011-03-10 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
|
BR112012008833A2
(pt)
|
2009-10-15 |
2015-09-08 |
Abbott Lab |
imunoglobulinas de dominio variavel duplo e usos das mesmas
|
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
WO2011104307A2
(en)
|
2010-02-25 |
2011-09-01 |
Graffinity Pharmaceuticals Gmbh |
Ligands for antibody purification by affinity chromatography
|
|
GB201004761D0
(en)
|
2010-03-22 |
2010-05-05 |
Medical Res Council |
Method
|
|
WO2011140279A1
(en)
|
2010-05-04 |
2011-11-10 |
Wayne State University |
Aav-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells
|
|
EP3252072A3
(en)
|
2010-08-03 |
2018-03-14 |
AbbVie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
US8962804B2
(en)
|
2010-10-08 |
2015-02-24 |
City Of Hope |
Meditopes and meditope-binding antibodies and uses thereof
|
|
US8865881B2
(en)
|
2011-02-22 |
2014-10-21 |
California Institute Of Technology |
Delivery of proteins using adeno-associated virus (AAV) vectors
|
|
CN102219859B
(zh)
|
2011-05-20 |
2012-09-12 |
烟台荣昌生物工程有限公司 |
拮抗血管新生诱导因子的融合蛋白及其用途
|
|
US20130090375A1
(en)
|
2011-10-06 |
2013-04-11 |
Cornell University |
Virus-mediated delivery of bevacizumab for therapeutic applications
|
|
AU2013240248B2
(en)
|
2012-03-26 |
2018-12-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Delivery of packaged RNA to mammalian cells
|
|
US9029510B2
(en)
|
2012-03-30 |
2015-05-12 |
Sorrento Therapeutics, Inc. |
Fully human antibodies that bind to VEGFR2 and methods of use thereof
|
|
TWI698240B
(zh)
|
2012-05-15 |
2020-07-11 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
|
|
US20150147317A1
(en)
|
2012-06-01 |
2015-05-28 |
Momenta Pharmaceuticals, Inc. |
Methods related to bevacizumab
|
|
US12024568B2
(en)
|
2012-09-13 |
2024-07-02 |
Cornell University |
Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
|
|
CN104662161A
(zh)
|
2012-09-19 |
2015-05-27 |
弗·哈夫曼-拉罗切有限公司 |
用于防止正亮氨酸错误地掺入蛋白质中的方法和组合物
|
|
EP2992021B1
(en)
|
2013-04-30 |
2020-07-22 |
Intas Pharmaceuticals Limited |
Novel cloning, expression & purification method for the preparation of ranibizumab
|
|
EP3044231B1
(en)
*
|
2013-09-12 |
2020-08-05 |
BioMarin Pharmaceutical Inc. |
Aav vectors comprising a gene encoding factor viii
|
|
CN106232618A
(zh)
*
|
2013-10-11 |
2016-12-14 |
马萨诸塞眼科耳科诊所 |
预测祖先病毒序列的方法及其用途
|
|
WO2015123715A1
(en)
|
2014-02-21 |
2015-08-27 |
Vegenics Pty Limited |
Ligand binding molecules and uses thereof
|
|
EP4678754A3
(en)
|
2014-03-11 |
2026-04-08 |
Wayne State University |
A modified mglur6 promoter and methods of use
|
|
CA2942501A1
(en)
|
2014-03-17 |
2015-09-24 |
Tapimmune Inc. |
Nucleic acid molecule vaccine compositions and uses thereof
|
|
WO2015140638A1
(en)
|
2014-03-18 |
2015-09-24 |
Korea Advanced Institute Of Science And Technology (Kaist) |
Glycosylated vegf decoy receptor fusion protein
|
|
ES2833230T3
(es)
|
2014-05-13 |
2021-06-14 |
Univ Pennsylvania |
Composiciones que comprenden AVV que expresan construcciones y usos de doble anticuerpo del mismo
|
|
CA2972714A1
(en)
|
2014-09-09 |
2016-03-17 |
Unum Therapeutics |
Chimeric receptors and uses thereof in immune therapy
|
|
WO2016094872A1
(en)
|
2014-12-12 |
2016-06-16 |
The Broad Institute Inc. |
Dead guides for crispr transcription factors
|
|
US10946094B2
(en)
|
2015-02-24 |
2021-03-16 |
Cornell University |
Adenoassociated viral mediated persistant anti-VEGF therapy for ovarian cancer
|
|
MX390848B
(es)
|
2015-06-23 |
2025-03-21 |
Childrens Hospital Philadelphia |
Factor ix modificado, y composiciones, metodos y usos para la transferencia de genes a celulas, organos y tejidos.
|
|
AU2016315703A1
(en)
|
2015-08-31 |
2018-03-08 |
The Trustees Of The University Of Pennsylvania |
Chimeric AAV-anti-VEGF for treating cancer in canines
|
|
WO2017050825A1
(en)
|
2015-09-21 |
2017-03-30 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
A method for quantifying bevacizumab
|
|
GB201518979D0
(en)
|
2015-10-27 |
2015-12-09 |
Univ Leuven Kath |
Treatment of hepatic steatosis related oligo-ovulation
|
|
CN108779167A
(zh)
|
2015-10-28 |
2018-11-09 |
宾夕法尼亚州大学信托人 |
鞘内施用腺伴随病毒载体用于基因治疗
|
|
SG10201913266UA
(en)
|
2015-12-11 |
2020-02-27 |
Massachusetts Eye & Ear Infirmary |
Materials and methods for delivering nucleic acids to cochlear and vestibular cells
|
|
KR20250057128A
(ko)
|
2015-12-30 |
2025-04-28 |
코디악 사이언시스 인코포레이티드 |
항체 및 이의 접합체
|
|
WO2017147265A1
(en)
|
2016-02-23 |
2017-08-31 |
Salk Institute For Biological Studies |
High throughput assay for measuring adenovirus replication kinetics
|
|
KR20240005973A
(ko)
|
2016-04-15 |
2024-01-12 |
리젠엑스바이오 인크. |
완전히-인간형의 번역후 변형된 항-VEGF Fab를 이용한 눈 질환의 치료
|
|
SG11201808426XA
(en)
*
|
2016-04-15 |
2018-10-30 |
Univ Pennsylvania |
Compositions for treatment of wet age-related macular degeneration
|
|
KR20190038536A
(ko)
|
2016-06-16 |
2019-04-08 |
애드베룸 바이오테크놀로지스, 인코포레이티드 |
안구 혈관신생을 저하시키기 위한 조성물 및 방법
|
|
ES2840059T3
(es)
|
2016-06-16 |
2021-07-06 |
Adverum Biotechnologies Inc |
Tratamiento de la DMRE mediante el uso de la variante AAV2 con aflibercept
|
|
EP3510161A4
(en)
*
|
2016-08-23 |
2020-04-22 |
Akouos, Inc. |
COMPOSITIONS AND METHODS FOR TREATING PERSONAL HEARING LOSS IN A PERSON
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
EP3687464A4
(en)
|
2017-09-27 |
2021-09-29 |
REGENXBIO Inc. |
TREATMENT OF EYE DISEASES WITH A TOTALLY HUMAN POST-TRANSLATION MODIFIED ANTI-VEGF FAB
|
|
MX2020003888A
(es)
|
2017-10-18 |
2020-11-06 |
Regenxbio Inc |
Anticuerpos terapeuticos postraduccionalmente modificados completamente humanos.
|
|
CN111770999A
(zh)
|
2017-11-27 |
2020-10-13 |
4D分子治疗有限公司 |
腺相关病毒变体衣壳和用于抑制血管生成的应用
|
|
US20240335560A1
(en)
|
2017-11-27 |
2024-10-10 |
4D Molecular Therapeutics Inc |
Adeno-associated virus variant capsids and use for inhibiting angiogenesis
|
|
CA3084733A1
(en)
|
2017-12-14 |
2019-06-20 |
Crispr Therapeutics Ag |
Materials and methods for treatment of autosomal dominant cone-rod dystrophy
|
|
EP3727468A4
(en)
*
|
2017-12-19 |
2021-09-22 |
Akouos, Inc. |
AAV-MEDIATED THERAPEUTIC ANTIBODIES DELIVERY TO THE INTERNAL EAR
|
|
US12558434B2
(en)
*
|
2018-02-20 |
2026-02-24 |
The Trustees Of The University Of Pennsylvania |
Compositions for treatment of wet age-related macular degeneration
|
|
EP4063510A1
(en)
*
|
2018-11-07 |
2022-09-28 |
Akouos, Inc. |
Use of adeno-associated viral vectors to correct gene defects/ express proteins in hair cells and supporting cells in the inner ear
|
|
WO2020206098A1
(en)
|
2019-04-03 |
2020-10-08 |
Regenxbio Inc. |
Gene therapy for eye pathologies
|
|
WO2020219868A1
(en)
|
2019-04-24 |
2020-10-29 |
Regenxbio Inc. |
Fully-human post-translationally modified antibody therapeutics
|
|
CN114502197A
(zh)
|
2019-08-26 |
2022-05-13 |
再生生物股份有限公司 |
用全人经翻译后修饰的抗VEGF Fab治疗糖尿病性视网膜病变
|
|
WO2021046245A1
(en)
|
2019-09-04 |
2021-03-11 |
University Of Massachusetts |
Adeno-associated virus vector platform for delivery of kh902 (conbercept) and uses thereof
|
|
WO2021071835A1
(en)
|
2019-10-07 |
2021-04-15 |
Regenxbio Inc. |
Adeno-associated virus vector pharmaceutical composition and methods
|
|
JP2022552375A
(ja)
|
2019-10-15 |
2022-12-15 |
コーネル・ユニバーシティー |
遺伝子治療発現カセットからの発現レベルを調節するための方法
|
|
WO2021091938A1
(en)
|
2019-11-04 |
2021-05-14 |
Decibel Therapeutics, Inc. |
Cochlear outer hair cell promoters and uses thereof
|
|
WO2021108530A1
(en)
|
2019-11-26 |
2021-06-03 |
University Of Massachusetts |
Recombinant adeno-associated virus for delivery of kh902 (conbercept) and uses thereof
|
|
WO2021231808A2
(en)
|
2020-05-13 |
2021-11-18 |
Akouos, Inc. |
Compositions and methods for treating gjb2-associated hearing loss
|
|
WO2021255589A1
(en)
|
2020-06-16 |
2021-12-23 |
Intas Pharmaceuticals Ltd. |
An anti-vegf scfab adeno-associated virus (aav) vector and uses thereof
|
|
WO2021255590A1
(en)
|
2020-06-16 |
2021-12-23 |
Intas Pharmaceuticals Ltd. |
An anti-vegf scfv adeno-associated virus (aav) vector and uses thereof
|
|
JP7842082B2
(ja)
|
2020-07-21 |
2026-04-07 |
エフティージェン コーポレーション |
眼疾患を処置するための組成物および方法
|
|
CA3192736A1
(en)
|
2020-09-03 |
2022-03-10 |
University Of Massachusetts |
Adeno-associated virus for delivery of kh902 (conbercept) and uses thereof
|
|
KR20230106598A
(ko)
|
2020-10-07 |
2023-07-13 |
리젠엑스바이오 인크. |
겔 제형과 같은 맥락막위 투여용 제형
|
|
CA3198368A1
(en)
|
2020-10-07 |
2022-04-14 |
Regenxbio Inc. |
Formulations for suprachoroidal administration such as formulations with aggregate formation
|
|
CA3198372A1
(en)
|
2020-10-07 |
2022-04-14 |
Regenxbio Inc. |
Formulations for suprachoroidal administration such as high viscosity formulations
|
|
IL303317A
(en)
|
2020-12-01 |
2023-07-01 |
Akouos Inc |
ANTI-NATURAL ANTIBODY STRUCTURES AND RELATED METHODS FOR THE TREATMENT OF SYMPTOMS ASSOCIATED WITH VESTIBULAR SWANNOMA
|
|
EP4305157A1
(en)
|
2021-03-09 |
2024-01-17 |
Huidagene Therapeutics (Singapore) Pte. Ltd. |
Engineered crispr/cas13 system and uses thereof
|
|
MX2023013394A
(es)
|
2021-05-13 |
2023-12-14 |
Akouos Inc |
Composiciones de suministro de terapia genica y metodos para tratar perdida auditiva.
|
|
EP4368203A4
(en)
|
2021-07-05 |
2025-09-24 |
Wuhan Neurophth Biotechnology Ltd Company |
CONSTRUCTION AND USE OF ANTI-VEGF ANTIBODIES IN AN IN VIVO EXPRESSION SYSTEM
|
|
WO2023283962A1
(en)
|
2021-07-16 |
2023-01-19 |
Huigene Therapeutics Co., Ltd. |
Modified aav capsid for gene therapy and methods thereof
|
|
CA3228501A1
(en)
|
2021-08-09 |
2023-02-16 |
Sicong DONG |
Bispecific fusion polypeptide and application thereof
|
|
TW202342525A
(zh)
|
2022-02-02 |
2023-11-01 |
美商阿科奧斯公司 |
用於治療前庭神經鞘瘤相關症狀之抗ｖｅｇｆ抗體構築體及相關方法
|
|
AU2023220237A1
(en)
|
2022-02-21 |
2024-08-15 |
Shanghai Regenelead Therapies Co., Ltd |
Vegf-binding molecule and pharmaceutical use thereof
|
|
CN117304307A
(zh)
|
2022-06-27 |
2023-12-29 |
上海鼎新基因科技有限公司 |
一种治疗新生血管相关眼底疾病的aav药物
|
|
KR20260005328A
(ko)
|
2023-04-28 |
2026-01-09 |
청두 오리젠 바이오테크놀로지 씨오., 엘티디. |
항vegf 단백질을 코딩하는 핵산, 폴리뉴클레오타이드 발현 카세트 및 재조합 아데노 관련 바이러스
|